Cargando…

MINDY1 promotes breast cancer cell proliferation by stabilizing estrogen receptor α

Breast cancer is the most commonly diagnosed malignant tumor among females. Estrogen receptor α (ERα) is initially expressed in 70% of breast cancers and is a well-known target of endocrine therapy for ERα-positive breast cancer. In the present study, we identified MINDY1, a member belongs to the mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Jianing, Luo, Yongwen, Long, Guo, Zhou, Ledu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514509/
https://www.ncbi.nlm.nih.gov/pubmed/34645792
http://dx.doi.org/10.1038/s41419-021-04244-z